<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03521739</url>
  </required_header>
  <id_info>
    <org_study_id>2018-993</org_study_id>
    <nct_id>NCT03521739</nct_id>
  </id_info>
  <brief_title>Association of Synchronous Four-limb blOod pRessure and Pulse Wave velocIty With Cardiovascular Events</brief_title>
  <acronym>ASORPWICE</acronym>
  <official_title>A National Registry for the Association of Synchronous Four-limb Blood Pressure and Pulse Wave Velocity With Cardiovascular Events in China</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chinese Academy of Medical Sciences, Fuwai Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chinese Academy of Medical Sciences, Fuwai Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A multicenter prospective registry planned to recruit more than 100 000 patients 50 years old
      and older was carried out in China. This primary purpose of this study was to evaluate the
      association of synchronous four-limb blood pressure and pulse wave velocity with
      cardiovascular events. The secondary purpose was to evaluate the incidence rate,prevalence
      rate, value of diagnosis for peripheral arterial occlusive disease, and to follow up the
      effects of revascularization on cardiovascular events.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Although many studies with the correlation between synchronous four-limb blood pressure and
      pulse velocity measurement and cardiovascular outcomes have existed currently, the sample
      sizes are relatively small and the data on Chinese populations are lacking.Therefore, a
      multicenter prospective registry planned to recruit more than 100 000 patients aged 50 years
      old and older was carried out in China. This primary purpose of this study was to evaluate
      the association of synchronous four-limb blood pressure and pulse wave velocity with
      cardiovascular events in chinese populations. The secondary purpose was to evaluate the
      incidence rate,prevalence rate, value of diagnosis for peripheral arterial occlusive disease,
      and to follow up the effects of revascularization on cardiovascular events.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2018</start_date>
  <completion_date type="Anticipated">December 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>5 Years</target_duration>
  <primary_outcome>
    <measure>Incidence of cardiovascular events (cardiovascular death,myocardial infarction, heart failure, stroke, renal failure, aortic dissection)</measure>
    <time_frame>From date of enrollment until the date of first documented cardiovascular events or date of death from any cause, whichever came first, assessed up to 12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of cardiovascular events (cardiovascular death,myocardial infarction, heart failure, stroke, renal failure, aortic dissection)</measure>
    <time_frame>Measured at 6 months, 24 months and every 12 months thereafter from date of enrollment until the date of first documented cardiovascular events or date of death from any cause, whichever came first, assessed up to 60 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of death from any cause</measure>
    <time_frame>Measured at 6 months, 12 months and every 12 months thereafter from date of enrollment until the date of first documented death from any cause, assessed up to 60 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of peripheral arterial disease</measure>
    <time_frame>Measured at 6 months, 12 months and every 12 months thereafter from date of enrollment until the date of first documented four-limb peripheral arterial disease or date of death from any cause, whichever came first, assessed up to 60 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of limb gangrene</measure>
    <time_frame>Measured at 6 months, 12 months and every 12 months thereafter from date of enrollment until the date of first documented gangrene caused by peripheral arterial disease or date of death from any cause,whichever came first, assessed up to 60 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of amputation</measure>
    <time_frame>Measured at 6 months, 12 months and every 12 months thereafter from date of enrollment until the date of first documented amputation caused by peripheral arterial disease or date of death from any cause, whichever came first, assessed up to 60 months</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">100000</enrollment>
  <condition>Blood Pressure</condition>
  <condition>Pulse Wave Analysis</condition>
  <condition>Ankle Brachial Index</condition>
  <condition>Patient Outcome Assessment</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Chinese populations with age ≥ 50 years old at the time of informed consent in hospital,
        community and physical examination center
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age ≥ 50 years old at the time of informed consent

          2. Chinese populations in hospital, community and physical examination center

        Exclusion Criteria:

          1. Patients with lack of limb,malformation of limbs, severe limb trauma or infection.

          2. Serious organic disease affecting the quality of life, such as tumors, massive
             cerebral infarction, uremia, and etc.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xiongjing Jiang, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Xiongjing Jiang, MD</last_name>
    <phone>86-1088322385</phone>
    <email>jxj103@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Hui Dong, MD</last_name>
    <phone>+8615810161393</phone>
    <email>donghui666@sina.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Beijing Renhe Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>010</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Yan Li, MD</last_name>
      <phone>86-010-69242469</phone>
      <email>654562304@qq.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Chinese PLA General Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>010</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Yu Wang, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>010</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiongjing Jiang, MD</last_name>
      <phone>86-1088322385</phone>
      <email>jxj103@hotmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Daping Hospital</name>
      <address>
        <city>Chongqing</city>
        <state>Chongqing</state>
        <zip>023</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Zhigang Zhao, MD</last_name>
      <phone>86-023-68811229</phone>
      <email>zhaozgsir@126.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Second Affiliated Hospital of Chongqing Medical University</name>
      <address>
        <city>Chongqing</city>
        <state>Chongqing</state>
        <zip>023</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jin Huang, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Lanzhou University Second Hospital</name>
      <address>
        <city>Lanzhou</city>
        <state>Gansu</state>
        <zip>0931</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jing Yu, MD</last_name>
      <phone>86-0931-8942262</phone>
      <email>yujing2304@126.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Guangdong General Hospital</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>020</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jianfang Luo, MD</last_name>
      <phone>86-020-83827812</phone>
      <email>henryjfl@tom.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Eighth Affiliated Hospital of Sun Yat-sen University</name>
      <address>
        <city>Shenzhen</city>
        <state>Guangdong</state>
        <zip>0755</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Nan Jia, MD</last_name>
      <phone>86-0755-83982222</phone>
      <email>jiananchina@hotmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kailuan General Hospital</name>
      <address>
        <city>Tangshan</city>
        <state>Hebei</state>
        <zip>0315</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Shouling Wu, MD</last_name>
      <email>drwusl@163.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Nanchang University</name>
      <address>
        <city>Nanchang</city>
        <state>Jiangxi</state>
        <zip>0791</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Zeqi Zheng, MD</last_name>
      <phone>86-0791-88692748</phone>
      <email>zeqizheng@126.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Second Affiliated Hospital of Nanchang University</name>
      <address>
        <city>Nanchang</city>
        <state>Jiangxi</state>
        <zip>0791</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ping Li, MD</last_name>
      <phone>86-0791-86297662</phone>
      <email>lipingsydney@163.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The General Hospital of Shenyang Military</name>
      <address>
        <city>Shenyang</city>
        <state>Liaoning</state>
        <zip>024</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Xiaozeng Wang, MD</last_name>
      <phone>86-024-28886666</phone>
      <email>wxiaozeng@163.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ruijin Hospital, Shanghai Jiaotong University School of Medicine</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>021</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jianzhong Xu, MD</last_name>
      <phone>86-021-64370045</phone>
      <email>jianzhongxv@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Shanghai East Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>021</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Qi Zhang, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Shanxi Cardiovascular Hospital</name>
      <address>
        <city>Taiyuan</city>
        <state>Shanxi</state>
        <zip>0351</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Bin Yang, MD</last_name>
      <phone>86-0351-5661145</phone>
      <email>yangbxys@163.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Xi'an Jiaotong University</name>
      <address>
        <city>Xi'an</city>
        <state>Shanxi</state>
        <zip>029</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Hongyan Tian, MD</last_name>
      <phone>86-029-85252580</phone>
      <email>tianhhyy@mail.xjtu.edu.cn</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Xi'an NO.3 Hospital</name>
      <address>
        <city>Xi'an</city>
        <state>Shanxi</state>
        <zip>029</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Kang Cheng, MD</last_name>
      <phone>86-029-61895566</phone>
      <email>chengkang2009@foxmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>West China Hospital of Sichuan University</name>
      <address>
        <city>Chengdu</city>
        <state>Sichuan</state>
        <zip>028</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Xiaoping Chen, MD</last_name>
      <phone>86-028-85422114</phone>
      <email>chenxp13@aliyun.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Zhejiang Hospital</name>
      <address>
        <city>Hangzhou</city>
        <state>Zhejiang</state>
        <zip>0571</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Lijiang Tang, MD</last_name>
      <phone>86-0571-87987373</phone>
      <email>lxw_76@163.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 11, 2018</study_first_submitted>
  <study_first_submitted_qc>April 28, 2018</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 10, 2018</study_first_posted>
  <last_update_submitted>April 28, 2018</last_update_submitted>
  <last_update_submitted_qc>April 28, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 10, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chinese Academy of Medical Sciences, Fuwai Hospital</investigator_affiliation>
    <investigator_full_name>Xiongjing Jiang</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>blood pressure</keyword>
  <keyword>pulse wave velocity</keyword>
  <keyword>ankle brachial index</keyword>
  <keyword>cardiovascular events</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

